Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Scientists have pinpointed a protein called Miro1 that may be a key driver of insulin resistance in type 2 diabetes. Found at elevated levels in the skeletal muscles of people with the disease, removing it in preclinical models restored insulin responsiveness. Even better — exercise was shown to naturally lower Miro1 levels, offering a fresh molecular explanation for why staying active helps manage blood sugar.
Scientists have identified a little-known protein called Miro1 (Mitochondrial Rho GTPase1) that may be a central culprit behind insulin resistance in type 2 diabetes. Found on the outer membrane of mitochondria — the cell's energy-producing powerhouses — Miro1 accumulates in the skeletal muscles of people with the disease, impairing the muscles' ability to respond to insulin and regulate blood sugar. The findings, published in Nature Communications, were led by Dr. John P. Kirwan and his team at LSU's Pennington Biomedical Research Center.
In preclinical models, removing Miro1 fully restored insulin responsiveness in muscle tissue — a causal link that strengthens the case for it as a therapeutic target. A randomized controlled trial in people with obesity and type 2 diabetes also found that aerobic exercise reduced Miro1 levels, alongside measurable improvements in insulin sensitivity and muscle energy capacity.
Key Takeaways:
Why it matters: Insulin resistance in muscle is the cornerstone of type 2 diabetes, yet its molecular roots have remained elusive. Miro1 offers a concrete new target for drug development and deepens our understanding of why exercise is so therapeutically powerful — potentially paving the way for treatments that complement physical activity.
